Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

Plain-English Summary

This bill is a resolution in the U.S. House of Representatives that formally recognizes Charcot-Marie-Tooth (CMT) disease as a significant health condition deserving greater national attention and resources. CMT is one of the most common inherited neurological disorders, affecting the nerves that control muscle movement and sensation, particularly in the arms and legs. People with CMT may experience muscle weakness, difficulty walking, and loss of sensation, and there is currently no cure. The resolution acknowledges the impact this disease has on patients and their families across the country.

The bill specifically calls for stronger funding for the National Institute of Neurological Disorders and Stroke (NINDS), which is the branch of the National Institutes of Health (NIH) responsible for researching diseases like CMT. By expressing Congress's support for increased investment in this area, the resolution aims to highlight the importance of finding better treatments and, ultimately, a cure for CMT.

It is important to note that this type of bill is a resolution, meaning it does not create new laws, mandate spending, or directly allocate money. Instead, it serves as an official statement of Congress's values and priorities. Its practical effect depends on whether it influences future budget decisions or draws broader attention to CMT research funding. The bill primarily affects the estimated 3 million people worldwide — including roughly 150,000 Americans — who live with CMT disease.